Hospitals Mark Up Discounted Cancer Drugs as Much as 11 Times, Report Says

September 13, 2022

(Axios) – Safety net hospitals are marking up the cost of drugs they buy through the government’s discount drug program by as much as 11 times the cost, according to a new report provided first to Axios by the Community Oncology Alliance (COA). Why it matters: It’s the latest evidence of how providers can benefit from the federal 340B drug pricing program, which provides discounted medicines to ensure access to low-income patients. (Read More)